Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation.
Del Chierico F, Masi L, Petito V, Baldelli V, Puca P, Benvenuto R, Fidaleo M, Palucci I, Lopetuso LR, Caristo ME, Carrozza C, Giustiniani MC, Nakamichi N, Kato Y, Putignani L, Gasbarrini A, Pani G, Scaldaferri F.
Del Chierico F, et al. Among authors: fidaleo m.
Inflamm Bowel Dis. 2024 Dec 5;30(12):2259-2270. doi: 10.1093/ibd/izae135.
Inflamm Bowel Dis. 2024.
PMID: 38944815
Free PMC article.